AR058392A1 - USE OF SULFAMIDE BENZOFUSED HETEROCICLIC DERIVATIVES AS NEUROPROTECTING AGENTS - Google Patents

USE OF SULFAMIDE BENZOFUSED HETEROCICLIC DERIVATIVES AS NEUROPROTECTING AGENTS

Info

Publication number
AR058392A1
AR058392A1 ARP060105594A AR058392A1 AR 058392 A1 AR058392 A1 AR 058392A1 AR P060105594 A ARP060105594 A AR P060105594A AR 058392 A1 AR058392 A1 AR 058392A1
Authority
AR
Argentina
Prior art keywords
formula
group
integer
lower alkyl
benzofused
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR058392A1 publication Critical patent/AR058392A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente es un método para neuroproteccion, para tratar un trastorno neurodegenerativo agudo, para tratar un trastorno neurodegenerativo cronico y/o para prevenir la muerte o el dano neuronal luego de una lesion o trauma cerebral, de cráneo y/o de la médula espinal, que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente efectiva de uno o más derivados novedosos heterocíclicos benzo-fusionados de sulfamida de formula (1) y formula (2) como se definen aquí. Reivindicacion 1: Uso de un compuesto de formula (1) donde R1 y R2 se seleccionan, cada uno en forma independiente, del grupo que consiste en H y alquilo inferior; R4 se selecciona el grupo que consiste en H y alquilo inferior; a es un numero entero desde 1 hasta 2; el anillo R se selecciona del grupo que consiste en las formulas (3) a (9) donde b es un numero entero desde 0 hasta 4; y donde c es un numero entero desde 0 hasta 2; cada R5 se selecciona en forma independiente del grupo que consiste en halogeno, alquilo inferior y nitro; siempre que cuando el anillo R es como en formula (8) o (9), entonces a es 1; o una sal del mismo aceptable desde el punto de vista farmacéutico, para la fabricacion de un medicamento para neuroproteccion.This is a method for neuroprotection, to treat an acute neurodegenerative disorder, to treat a chronic neurodegenerative disorder and / or to prevent death or neuronal damage after an injury or brain, skull and / or spinal cord trauma, which comprises administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocyclic sulfamide derivatives of formula (1) and formula (2) as defined herein. Claim 1: Use of a compound of formula (1) wherein R1 and R2 are each independently selected from the group consisting of H and lower alkyl; R4 is selected from the group consisting of H and lower alkyl; a is an integer from 1 to 2; the ring R is selected from the group consisting of formulas (3) a (9) where b is an integer from 0 to 4; and where c is an integer from 0 to 2; each R5 is independently selected from the group consisting of halogen, lower alkyl and nitro; provided that when the R ring is as in formula (8) or (9), then a is 1; or a pharmaceutically acceptable salt thereof, for the manufacture of a drug for neuroprotection.

ARP060105594 2005-12-19 2006-12-18 USE OF SULFAMIDE BENZOFUSED HETEROCICLIC DERIVATIVES AS NEUROPROTECTING AGENTS AR058392A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75149405P 2005-12-19 2005-12-19

Publications (1)

Publication Number Publication Date
AR058392A1 true AR058392A1 (en) 2008-01-30

Family

ID=39060290

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105594 AR058392A1 (en) 2005-12-19 2006-12-18 USE OF SULFAMIDE BENZOFUSED HETEROCICLIC DERIVATIVES AS NEUROPROTECTING AGENTS

Country Status (5)

Country Link
CN (1) CN101374512B (en)
AR (1) AR058392A1 (en)
PE (1) PE20071008A1 (en)
TW (1) TWI435722B (en)
UA (1) UA96747C2 (en)

Also Published As

Publication number Publication date
TW200744582A (en) 2007-12-16
CN101374512A (en) 2009-02-25
PE20071008A1 (en) 2007-10-24
TWI435722B (en) 2014-05-01
UA96747C2 (en) 2011-12-12
CN101374512B (en) 2012-07-04

Similar Documents

Publication Publication Date Title
CO2020006224A2 (en) New catecholamine prodrugs for use in the treatment of parkinson's disease
PA8520301A1 (en) REPLACED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
RU2018106483A (en) COMPOUNDS SUITABLE FOR TREATING DISORDERS RELATED TO KIT AND PDGFR
AR058389A1 (en) USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY
ECSP099728A (en) AMINO-HETEROCYCLIC COMPOUNDS
PE20211090A1 (en) DERIVATIVES OF 1,3,4,5-TETRAHIDRO-2H-PIRIDO [4,3-B] INDOLE FOR THE TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES
AR063602A1 (en) DERIVATIVES OF SPIROINDOLINONE, PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM AND THEIR USE IN THE OBTAINING OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL DISORDERS.
AR054347A1 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
ECSP056115A (en) ANTAGONISTS OF A2A-2-ALQUINIL- AND 2-ALQUENIL-PIRAZOLO- [4,3-e] -1,2,4-TRIAZOLO- [1,5-c] -PIRIMIDINE ADENOSINE RECEPTOR
AR053364A1 (en) COMPOSITE OF 1H-IMIDAZO 84,5-C) PIRIDIN -2- ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCESS TO PREPARE IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT FOR TREATMENT OF CANCER OR ARTHRITIS
CR10419A (en) Pyrazolo [3,4-D] -Pyrimidine derivatives useful for treating respiratory disorders
AR051997A1 (en) TRICYCLIC HETEROCICLES, ITS OBTAINING AND USE OF THE SAME C OMO PHARMACEUTICAL AGENTS
UY28885A1 (en) 4-PHENYLAMINE-QUINAZOLIN-6-IL-AMIDAS CROSSED REFERENCE ON RELATED APPLICATION (S)
PA8680701A1 (en) OXINDOL DERIVATIVES
ECSP045253A (en) DERIVATIVES OF 5-PHENYLTIAZOL AND USE AS INHIBITORS OF PI3 CINASA
JP2009541223A5 (en)
AR108046A1 (en) INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE
AR063097A1 (en) PIRAZOLOPIRIMIDINAS [1,5-A] INHIBITORS OF CYCLINE-DEPENDENT KINASES (CDK), PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
DK1968571T3 (en) Use of benzo-condensed heterocyclic sulfamide derivatives as neuroprotective agents
JP2015528812A5 (en)
GT200600161A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS
ECSP056202A (en) DERIVATIVES OF IMIDAZOL AS ANTAGONISTS OF THE GLUTAMATE RECEIVER
JP2015535247A5 (en)
AR054000A1 (en) COMPOSITE OF N- (FENILPROPIL) -SULFONAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, COMBINATION PRODUCT THAT INCLUDES SUCH COMPOUND AND METHOD TO PREPARE IT
DK2319517T3 (en) APPLICATION OF PRODRUGS TO OCULAR, INTRAVENOUS ADMINISTRATION

Legal Events

Date Code Title Description
FA Abandonment or withdrawal